"Baylor Scott & White The Heart Hospital – Plano is a nationally ranked and recognized heart hospital and one of the premier cardiovascular centers in the nation, ranked #27 in the nation for Cardiology & Heart Surgery in the U.S. News & World Report 2019-20 Best Hospitals list and achieving “High Performing” in five types of care: Abdominal Aortic Aneurysm Repair, Aortic Valve Surgery, Heart Bypass Surgery, Congestive Heart Failure and Lung Cancer Surgery. Guests from 12 countries and 46 states have received nationally renowned cardiovascular care and personalized guest service here. From conquering heart failure to defeating lung cancer to thriving with a renewed heart, your fighting spirit is what drives us."

During the past decade, The Heart Hospital Baylor Plano conducted 79 clinical trials. In the 10-year time frame, 79 clinical trials started and 42 clinical trials were completed, i.e. on average, 53.2% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 28 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Heart Hospital Baylor Plano" #1 sponsor was "Edwards Lifesciences" with 23 trials, followed by "Baylor Research Institute" with 20 trials sponsored, "Abbott Medical Devices" with 12 trials sponsored, "Boston Scientific Corporation" with 11 trials sponsored and "Medtronic Cardiovascular" with 11 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Heart Hospital Baylor Plano" #1 collaborator was "Medtronic" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Boston Scientific Corporation" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator and "Maquet Cardiovascular" with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "The Heart Hospital Baylor Plano" are "Coronary Artery Disease" (16 trials), "Aortic Valve Stenosis" (13 trials), "Atrial Fibrillation" (9 trials), "Aortic Stenosis" (7 trials) and "Heart Failure" (6 trials). Many other conditions were trialed in "The Heart Hospital Baylor Plano" in a lesser frequency.

Most popular intervention types in "The Heart Hospital Baylor Plano" are "Device" (87 trials), "Drug" (17 trials), "Procedure" (12 trials), "Behavioral" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "DrugSorb-ATR system" (2 trials), "Edwards PASCAL System" (2 trials), "GORE® TAG® Thoracic Branch Endoprosthesis" (2 trials) and "Optimal Medical Therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Heart Hospital Baylor Plano" are 112 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Heart Hospital Baylor Plano". undefined are not yet recruiting, 23 are recruiting, 34 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 45 completed trials in The Heart Hospital Baylor Plano, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in The Heart Hospital Baylor Plano, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 78 trials that are defined as “Not Applicable".